Ventyx Biosciences Future Growth
Future criteria checks 0/6
Ventyx Biosciences is forecast to grow earnings and revenue by 5.8% and 77.4% per annum respectively while EPS is expected to grow by 24.7% per annum.
Key information
5.8%
Earnings growth rate
24.7%
EPS growth rate
| Pharmaceuticals earnings growth | 23.9% |
| Revenue growth rate | 77.4% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully
Nov 14
Ventyx Biosciences: Ready To Escape "The Crash Cycle"
Nov 04Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?
Jul 12Ventyx Biosciences: Slim Chances In A Fat Market (Rating Downgrade)
Jul 01Ventyx Pivots To Obesity Amid Transformation
Mar 12Here's Why We're Watching Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Situation
Feb 15Ventyx: Too Risky Right Now After Some Poor Data
Jan 18Companies Like Ventyx Biosciences (NASDAQ:VTYX) Are In A Position To Invest In Growth
Sep 21Ventyx Biosciences (NASDAQ:VTYX) Is In A Good Position To Deliver On Growth Plans
Jun 07We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate
Feb 20Ventyx Biosciences: Not Chasing This Rally
Sep 18We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth
Aug 19Ventyx Biosciences GAAP EPS of -$0.39 beats by $0.06
Aug 15Ventyx Biosciences autoimmune/autoinflammatory candidate meets phase 1 goals
Jun 29We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate
May 06We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth
Jan 21Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 18 | -183 | -202 | -168 | 5 |
| 12/31/2025 | N/A | -170 | -165 | -166 | 7 |
| 12/31/2024 | N/A | -144 | -86 | -133 | 7 |
| 9/30/2024 | N/A | -153 | -160 | -159 | N/A |
| 6/30/2024 | N/A | -171 | -159 | -158 | N/A |
| 3/31/2024 | N/A | -193 | -184 | -183 | N/A |
| 12/31/2023 | N/A | -193 | -167 | -167 | N/A |
| 9/30/2023 | N/A | -181 | -163 | -162 | N/A |
| 6/30/2023 | N/A | -158 | -152 | -151 | N/A |
| 3/31/2023 | N/A | -125 | -117 | -117 | N/A |
| 12/31/2022 | N/A | -108 | -99 | -99 | N/A |
| 9/30/2022 | N/A | -91 | -66 | -66 | N/A |
| 6/30/2022 | N/A | -73 | -54 | -53 | N/A |
| 3/31/2022 | N/A | -69 | -49 | -48 | N/A |
| 12/31/2021 | N/A | -85 | -39 | -39 | N/A |
| 9/30/2021 | N/A | -84 | -26 | -26 | N/A |
| 6/30/2021 | N/A | -79 | -17 | -17 | N/A |
| 3/31/2021 | N/A | -65 | -8 | -8 | N/A |
| 12/31/2020 | N/A | -28 | -6 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VTYX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VTYX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VTYX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VTYX is forecast to have no revenue next year.
High Growth Revenue: VTYX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VTYX's Return on Equity is forecast to be high in 3 years time